The Pervasive Threat of Antibiotic Resistance
The presence of high-quality water is essential not only for human survival but also for the well-being of plants and animals. However, the widespread and often indiscriminate use of antibiotics has led to the emergence of a formidable global health crisis – antibiotic resistance.
The etymology of the term “antibiotic” traces its roots to its literal interpretation as “against life.” Antibiotics represent a category of compounds, whether they occur naturally, are semi-synthetic, or are synthesized chemically, characterized by their antimicrobial attributes. Ubiquitously employed in the prevention and management of infectious diseases across animal and human populations, antibiotics serve as indispensable tools in the battle against microbial infections.
The advent of antibiotics in the mid-20th century has heralded a monumental revolution in the realm of medicine, saving innumerable lives. However, the extensive integration of these extraordinary medications has precipitated the rapid ascent of resistant strains. Experts within the medical fraternity now voice apprehensions regarding the looming specter of regressing to the pre-antibiotic epoch.
Investigations from various regions have underscored the disconcerting prevalence of antibiotics within wastewater effluents originating from pharmaceutical manufacturing facilities. This phenomenon engenders fluctuations across seasons, incurs ecological hazards, and fosters the proliferation of antibiotic-resistant bacteria (ARB) strains. The exigencies engendered by deficient wastewater management underscore the imperative for bolstered environmental stewardship.
The Spread of Antibiotic Resistance
The discovery of antibiotics, notably penicillin, was a major medical breakthrough in the early 20th century. However, bacterial resistance has emerged due to genetic variation caused by mutations in DNA coding regions. Antibiotic use in humans and agriculture has increased the frequency of antibiotic resistance genes (ARGs) through natural selection and horizontal gene transfer (HGT).
Microbial genomics has unveiled widespread ARGs in bacterial genomes, forming the “antibiotic resistome.” These genes are found in diverse ecological niches, suggesting coevolution with antibiotics. Metagenomic analysis of ancient DNA indicates that antibiotic resistance predates therapeutic antibiotic use.
Microorganisms utilize antibiotics as a means of self-defense, eliminating neighboring competitors and asserting dominance across varied environments. ARB and ARGs exist naturally, potentially originating tens of millions or even billions of years in the past. Recent evolutionary events contributing to their prevalence in pathogens primarily result from transfer events from ancestral species where the overall functionality of these genes was shaped.
The process leading to acquired resistance in pathogens typically involves several steps. Initially, an ARG gains the ability to move within the genome, often achieved through associations with insertion sequences or the formation of gene cassettes incorporated into integrons. Subsequently, the gene relocates to an element capable of autonomous movement between cells, such as a plasmid or integrative conjugative element.
The escalation of antimicrobial resistance (AMR) presents a critical global health emergency, spurred by the widespread consumption of antibiotics surpassing 73 billion standard units as of 2010. ARGs, with origins predating human antibiotic usage, have now proliferated extensively, propelled by environmental exposure to antibiotics.
Antibiotic Contamination in Aquatic Ecosystems
The pervasive specter of antibiotic contamination within environmental domains, encompassing aquatic ecosystems and public health spheres, in tandem with the burgeoning menace of antibiotic resistance among human populations, evokes profound alarm. Globally, the yearly usage of antibiotics exceeds 100,000 tons, prompting increasing concerns regarding the fate of these substances.
Antibiotics are ubiquitous in the environment, with significant levels detected in freshwater reservoirs. These pseudo-permanent pollutants provoke apprehension due to the emergence of ARB, thereby posing a significant hazard to human health. Analytical techniques like solid phase extraction (SPE) and rapid resolution liquid chromatography/tandem mass spectrometry (RRLC-MS/MS) have identified approximately 11 classifications of antibiotics in various environmental samples.
Wastewater treatment plants (WWTPs) receive inputs from diverse sources, exposing them to antibiotics, metals, and chemicals, which collectively foster an environment conducive to HGT. Despite mitigation efforts, research indicates that WWTPs are unable to entirely eradicate antibiotics, ARB, and ARGs. As a result, the release of WWTP effluent into environments such as surface water, groundwater, marine ecosystems, and soil introduces ARB and ARGs, potentially amplifying antibiotic resistance among indigenous environmental microorganisms.
The presence of various antibiotics in treated wastewater from scientific and military stations highlights that conventional WWTPs do not entirely remove these pharmaceuticals, leading to their release into adjacent seawater. Antibiotics have been detected at low ng/L levels in seawater samples near wastewater outfalls.
Endocrine Disruption and Reproductive Impacts
The endocrine system regulates numerous physiological functions within our bodies, which can be disrupted by a class of chemicals known as endocrine-disrupting compounds (EDCs). These compounds, which can be either natural or human-made, are predominantly of anthropogenic origin. EDCs have the capability to mimic, amplify, or hinder the actions of endocrine products, and they may also contribute to tumor formation.
A significant subset of EDCs interferes with sexual hormonal activities, leading to abnormalities in reproductive processes, embryonic development, sexual differentiation, and metabolic maturation. Studies have reported that EDCs impair reproduction and drastically decrease sperm quality and count, as well as exhibiting estrogenic effects in males.
The female reproductive cycle may be divided into fetal, prepubertal, cycling adult, pregnant, lactating, and reproductive senescent stages. Evaluation of each stage is necessary for studies regarding the endocrine toxicity of chemicals. Estrogenic chemicals have been shown to decrease gonadotropin output, resulting in atrophic adult female ovaries. Exposure to chlorotriazines caused some rat strains to remain in an estrous state for an extended period, likely due to a disturbance in the hypothalamic-pituitary regulation of ovarian function.
Chloroquine, originally employed as an antimalarial medication, has also been found to disrupt estrous cyclicity, as follicular steroidogenesis and pituitary hormone secretion depend on a calcium calmodulin-mediated response. Antineoplastic drugs like cyclophosphamide and vinblastine have been observed to inhibit the secretion of progesterone by human granulosa cells, demonstrating their potential reproductive toxicity.
Disruption of the male endocrine system can manifest at various stages and encompass a range of actions, spanning from the hypothalamus and pituitary gland to the testes. Chemicals that exhibit estrogenic, antiandrogenic, and Ah receptor-binding activity are the main culprits, as they can directly impact testosterone production or influence the regulation of gonadotropin production.
Pharmaceuticals in the Aquatic Environment
Pharmaceutical drugs play crucial roles in human, animal, agriculture, and aquaculture sectors, serving purposes like disease treatment and prevention. Their consumption has been steadily rising each year. However, the interaction of active compounds with other biological compounds can lead to unforeseen environmental consequences.
Therapeutic compounds find their way into the aquatic system through various sources, contaminating surface water with pharmaceutical substances and their metabolites. To preserve a healthy ecosystem and biodiversity of aquatic organisms, it’s crucial to maintain the quality of surface water.
Improper disposal of pharmaceutical compounds, coupled with inadequate wastewater treatment methods, can result in the accumulation of these compounds in the environment. This accumulation can adversely affect non-targeted organisms and induce stress on the ecosystem.
Drugs like paracetamol undergo metabolism in the gut after administration, with some becoming inactive before release into the environment. However, certain drugs can exit the body in their active form through excretion, potentially altering the nature of surface water bodies when they enter aquatic systems. This highlights the need for understanding the fate of pharmaceuticals in the environment and implementing measures to minimize their impact on water quality and ecosystems.
Strategies for Reducing Pharmaceutical Contamination
Effective measures to reduce the exposure of natural microbiomes to emerging contaminants, including pharmaceuticals, are needed. Two strategies can be followed to reduce the exposure of microbial communities to these pollutants:
- Reduce the Entrance of Emerging Contaminants in Drinking Water Distribution Systems (DWDS):
- Conventional drinking water treatment plants (DWTPs) are not effective in the complete removal of emerging contaminants. Coagulation, flocculation, and settling processes have limited ability to remove these pollutants.
- Filtration methods, such as activated carbon and biofiltration, can improve the removal of some emerging contaminants, but their efficiency is highly dependent on the specific compound and water matrix.
- Oxidation processes, including chlorination, chlorine dioxide treatment, peroxidation, and ozonation, have shown potential for the degradation of certain emerging contaminants. However, the use of these oxidants can also lead to the formation of carcinogenic disinfection by-products.
- Membrane filtration techniques, like nanofiltration and reverse osmosis, have demonstrated higher removal efficiencies for a broader range of emerging contaminants compared to conventional treatments.
-
Developing and implementing advanced treatment technologies, such as electrochemical processes and advanced oxidation, can enhance the removal of emerging contaminants in DWTPs.
-
Prevent Biofilm Development in Drinking Water Distribution Systems:
- Microbial biofilms are continuously exposed to emerging contaminants in DWDS, and the presence of these pollutants may alter the behavior and composition of the biofilm communities.
- Strategies to control biofilm development, such as maintaining proper disinfectant residuals, optimizing hydraulic conditions, and implementing regular pipe cleaning, can help reduce the exposure of microorganisms to emerging contaminants.
- Understanding the effects of emerging contaminants on the DWS microbiome is crucial for developing targeted mitigation strategies and ensuring the delivery of safe drinking water to consumers.
While the complete eradication of emerging contaminants from drinking water may not be feasible, a combination of advanced treatment technologies and effective biofilm management practices can help minimize the exposure of microbial communities and safeguard public health.
Conclusion
The pervasive presence of antibiotics in the environment, coupled with the alarming spread of antibiotic resistance, poses a significant threat to both human health and ecological equilibrium. Urgent strategies and responsible antibiotic practices are essential to address this escalating crisis.
The study’s focus on pharmaceutical contamination in aquatic ecosystems reveals the concerning endocrine-disrupting effects on both female and male reproductive cycles. Disturbances in estrous states, ovarian function, and sperm quality underscore the need for immediate measures to mitigate potential risks to ecosystem and human health.
The diverse sources of pharmaceutical contaminants, from improper disposal to hospital discharge and agricultural runoff, necessitate comprehensive evaluations and urgent actions to address these adverse effects. Neurotoxicity of drugs also underscores the critical importance of developing safer medications and improving public health through innovative research and strategies.
Coordinated global efforts are imperative to combat the crisis of antibiotic resistance and pharmaceutical contamination. Strengthening regulatory frameworks, enhancing surveillance and monitoring, improving waste management practices, and fostering public-private partnerships are crucial steps towards a sustainable future.
Joint Action for Water is committed to driving these essential changes and empowering communities to address the impacts of emerging contaminants and endocrine disruptors on water quality and public health. Together, we can build a resilient and safe water future for all.
